Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Heart Failure
  Free Subscription

Articles published in
J Cardiol
    May 2024
  1. VLACHAKIS PK, Tsiachris D, Doundoulakis I, Tsioufis P, et al
    Therapeutic inertia in rhythm control strategies in hospitalized patients with fibrillation: Insights from Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study.
    J Cardiol. 2024;83:313-317.
    >> Share

    April 2024
  2. MAKHOUL GW, Mustafa A, Wei C, Ling J, et al
    Heart failure - An unexplored risk factor for infective endocarditis after pacemaker implantation.
    J Cardiol. 2024 Apr 5:S0914-5087(24)00061-3. doi: 10.1016/j.jjcc.2024.
    >> Share

  3. SAITO S, Okubo S, Matsuoka T, Hirota S, et al
    Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
    J Cardiol. 2024;83:228-235.
    >> Share

    March 2024
  4. OHIRA T, Eguchi E, Hayashi F, Kinuta M, et al
    Epidemiology of cardiovascular disease in Japan: An overview study.
    J Cardiol. 2024;83:191-200.
    >> Share

  5. ONODA H, Imamura T, Ueno H, Oshima A, et al
    Prognostic impact of elevated erythropoietin levels in patients with severe aortic stenosis receiving trans-catheter aortic valve implantation.
    J Cardiol. 2024;83:149-154.
    >> Share

    February 2024
  6. YAKU H, Fudim M, Shah SJ
    Role of splanchnic circulation in the pathogenesis of heart failure: State-of-the-art review.
    J Cardiol. 2024 Feb 16:S0914-5087(24)00022-4. doi: 10.1016/j.jjcc.2024.
    >> Share

  7. SHIBATA T, Matsumoto S, Muramoto T, Matsukawa M, et al
    Comparison of the treatment status of patients with acute heart failure before and during the COVID-19 pandemic - Observational cohort study using Japanese administrative data.
    J Cardiol. 2024 Feb 2:S0914-5087(24)00011-X. doi: 10.1016/j.jjcc.2024.
    >> Share

    December 2023
  8. SATO K, Kamiya K, Hamazaki N, Nozaki K, et al
    Association of sarcopenia defined by different skeletal muscle mass measurements with prognosis and quality of life in older patients with heart failure.
    J Cardiol. 2023 Dec 20:S0914-5087(23)00305-2. doi: 10.1016/j.jjcc.2023.
    >> Share

    November 2023
  9. HEIDENREICH P
    Heart failure management guidelines: New recommendations and implementation.
    J Cardiol. 2023 Nov 8:S0914-5087(23)00271-X. doi: 10.1016/j.jjcc.2023.
    >> Share

    October 2023
  10. UCHIYAMA S, Toki M, Kitai T, Yoshioka K, et al
    Dynamic changes in echocardiographic parameters in acute decompensated heart failure: REALITY-ECHO.
    J Cardiol. 2023 Oct 24:S0914-5087(23)00268-X. doi: 10.1016/j.jjcc.2023.
    >> Share

  11. POL T, Karlstrom P, Lund LH
    Heart failure registries - Future directions.
    J Cardiol. 2023 Oct 14:S0914-5087(23)00257-5. doi: 10.1016/j.jjcc.2023.
    >> Share

  12. SI J, Ding Z, Hu Y, Zhang X, et al
    Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.
    J Cardiol. 2023 Oct 5:S0914-5087(23)00242-3. doi: 10.1016/j.jjcc.2023.
    >> Share

  13. OKAMURA M, Kataoka Y, Taito S, Fujiwara T, et al
    Early mobilization for acute heart failure: A scoping and a systematic review.
    J Cardiol. 2023 Oct 3:S0914-5087(23)00239-3. doi: 10.1016/j.jjcc.2023.
    >> Share

    September 2023
  14. SEO M, Watanabe T, Yamada T, Morita T, et al
    The clinical relevance of mild cognitive impairment in acute heart failure: A comparison with cognitive impairment.
    J Cardiol. 2023 Sep 6:S0914-5087(23)00222-8. doi: 10.1016/j.jjcc.2023.
    >> Share

  15. MATSUDA H, Kuragaichi T, Sato Y
    Investigating the seasonal variation of heart failure hospitalizations and in-hospital mortality risks in Japan using a nationwide database.
    J Cardiol. 2023 Sep 2:S0914-5087(23)00219-8. doi: 10.1016/j.jjcc.2023.
    >> Share

    August 2023
  16. HORIBE H, Ando K, Maekawa Y, Narisawa M, et al
    The association of serum adiponectin level with activities of daily living in hospitalized elderly patients with heart failure.
    J Cardiol. 2023 Aug 15:S0914-5087(23)00202-2. doi: 10.1016/j.jjcc.2023.
    >> Share

  17. HARRISON NE, Ehrman R, Collins S, Desai AA, et al
    The prognostic value of improving congestion on lung ultrasound during treatment for acute heart failure differs based on patient characteristics at admission.
    J Cardiol. 2023 Aug 12:S0914-5087(23)00190-9. doi: 10.1016/j.jjcc.2023.
    >> Share

  18. ICHIHARA YK, Kohsaka S, Kisanuki M, Sandhu ATS, et al
    Implementation of evidence-based heart failure management: Regional variations between Japan and the USA.
    J Cardiol. 2023 Aug 3:S0914-5087(23)00185-5. doi: 10.1016/j.jjcc.2023.
    >> Share

  19. KLARSKOV VR, Ladefoged BT, Pedersen ALD, Hartig-Andreasen C, et al
    Clinical characteristics and prognostic implications of orthopedic ligament disorders in patients with wild-type transthyretin amyloidosis cardiomyopathy.
    J Cardiol. 2023;82:122-127.
    >> Share

    July 2023
  20. YUASA N, Obokata M, Harada T, Kagami K, et al
    Characterization and Prognostic Importance of Chronotropic Incompetence in Heart Failure with Preserved Ejection Fraction.
    J Cardiol. 2023 Jul 5:S0914-5087(23)00159-4. doi: 10.1016/j.jjcc.2023.
    >> Share

  21. FERREIRA JP, Zannad F, Kiernan MS, Konstam MA, et al
    High- versus low-dose losartan and uric acid: An analysis from HEAAL.
    J Cardiol. 2023;82:57-61.
    >> Share

  22. UGATA Y, Hayashi T, Yamamoto S, Fujita H, et al
    Impact of Q wave in synthesized V7-9 lead on long-term outcomes after cardiac resynchronization therapy.
    J Cardiol. 2023;82:51-56.
    >> Share

  23. MATSUURA K, Kumamaru H, Kohsaka S, Kanda T, et al
    Impact of concomitant mitral regurgitation during transcatheter aortic valve replacement on 1-year survival outcomes.
    J Cardiol. 2023;82:16-21.
    >> Share

  24. NAKAGAWA S, Takahama H, Hoshino K, Yanagi Y, et al
    Prevalence and predictive factors for clinical outcomes of isolated functional tricuspid regurgitation.
    J Cardiol. 2023;82:8-15.
    >> Share

    June 2023
  25. BHATIA K, Sabharwal B, Gupta K, Lopez PD, et al
    Clinical outcomes of intravenous Iron therapy in patients with heart failure and Iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials.
    J Cardiol. 2023 Jun 26:S0914-5087(23)00157-0. doi: 10.1016/j.jjcc.2023.
    >> Share

  26. GUDENKAUF B, Shaya G, Mukherjee M, Michos ED, et al
    Insulin resistance is associated with subclinical myocardial dysfunction and reduced functional capacity in heart failure with preserved ejection fraction.
    J Cardiol. 2023 Jun 24:S0914-5087(23)00153-3. doi: 10.1016/j.jjcc.2023.
    >> Share

  27. HUANG HT, Ko SL, Wang CY, Lo HC, et al
    Risk stratification for worsening renal function and renal decline in heart failure patients with reduced ejection fraction after sacubitril/valsartan treatment.
    J Cardiol. 2023 Jun 7:S0914-5087(23)00129-6. doi: 10.1016/j.jjcc.2023.
    >> Share

    May 2023
  28. NOGI K, Yamamoto R, Ueda T, Nogi M, et al
    Derivation and validation of a clinical predictive model of NT-proBNP >/=125 pg/mL to detect pre-heart failure.
    J Cardiol. 2023 May 27:S0914-5087(23)00126-0. doi: 10.1016/j.jjcc.2023.
    >> Share

  29. KATAOKA N, Imamura T
    Prognostic impact of xanthine oxidoreductase activity in patients with heart failure and atrial fibrillation.
    J Cardiol. 2023 May 24:S0914-5087(23)00115-6. doi: 10.1016/j.jjcc.2023.
    >> Share

  30. TOGASHI I, Sato T
    Conduction system pacing: Current status and prospects.
    J Cardiol. 2023;81:413-419.
    >> Share

  31. SHIBASAKI I, Otani N, Saito S, Ogawa H, et al
    Overview of mechanical circulatory support for the management of post-myocardial infarction ventricular septal rupture.
    J Cardiol. 2023;81:491-497.
    >> Share

    April 2023
  32. TAMAKI Y, Iwano H, Murayama M, Ishizaka S, et al
    Application of an echocardiographic scoring system of left ventricular filling pressure to diagnose acute heart failure in patients complaining dyspnea.
    J Cardiol. 2023 Apr 28:S0914-5087(23)00100-4. doi: 10.1016/j.jjcc.2023.
    >> Share

  33. SEGEV A, Maor E, Goldenfeld M, Itelman E, et al
    Atrial fibrillation in young hospitalized patients: clinical characteristics, predictors of new onset, and outcomes.
    J Cardiol. 2023 Apr 26:S0914-5087(23)00096-5. doi: 10.1016/j.jjcc.2023.
    >> Share

  34. JOKI Y, Konishi H, Takasu K, Minamino T, et al
    Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice.
    J Cardiol. 2023;81:347-355.
    >> Share

  35. SHINKAWA T, Ichihara Y, Saito S, Ishido M, et al
    Ventricular assist device for end-stage adult congenital heart disease patients: Current status.
    J Cardiol. 2023;81:378-384.
    >> Share

    March 2023
  36. KINOSHITA M, Saito M, Inoue K, Nakagawa H, et al
    Role of the right ventricular contractile reserve during low-load exercise in predicting heart failure readmission.
    J Cardiol. 2023 Mar 8:S0914-5087(23)00049-7. doi: 10.1016/j.jjcc.2023.
    >> Share

  37. IMAMURA T, Narang N, Kinugawa K
    Clinical implications of remote dielectric sensing system to estimate lung fluid levels.
    J Cardiol. 2023;81:276-282.
    >> Share

    February 2023
  38. MISUMI K, Matsue Y, Nogi K, Fujimoto Y, et al
    Derivation and validation of a machine learning-based risk prediction model in patients with acute heart failure.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00045-X. doi: 10.1016/j.jjcc.2023.
    >> Share

  39. TSUTSUI H, Sakamaki H, Momomura SI, Sakata Y, et al
    Cost-effectiveness analysis of Empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-reduced trial.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00046-1. doi: 10.1016/j.jjcc.2023.
    >> Share

  40. WATANABE K, Arimoto T, Watanabe T, Otaki Y, et al
    Prognostic impact of plasma xanthine oxidoreductase activity in patients with heart failure with atrial fibrillation.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00042-4. doi: 10.1016/j.jjcc.2023.
    >> Share

  41. LI M, Ma W, Fan F, Yi T, et al
    Renal denervation in management of heart failure with reduced ejection fraction: A systematic review and meta-analysis.
    J Cardiol. 2023 Feb 7:S0914-5087(23)00021-7. doi: 10.1016/j.jjcc.2023.
    >> Share

    December 2022
  42. KINUGAWA K, Matsukawa M, Nakamura Y, Aihara M, et al
    Impact of tolvaptan add-on treatment on patients with heart failure requiring long-term congestion management: A retrospective cohort study using a medical claim database in Japan.
    J Cardiol. 2022 Dec 29:S0914-5087(22)00323-9. doi: 10.1016/j.jjcc.2022.
    >> Share

  43. SHIMOMOTO R, Kubo T, Yamanaka F, Tsuchihashi-Makaya M, et al
    Current state of knowledge and information sharing among home healthcare professionals involved in heart failure management.
    J Cardiol. 2022 Dec 13:S0914-5087(22)00312-4. doi: 10.1016/j.jjcc.2022.
    >> Share

  44. CHIBA Y, Iwano H, Aoyagi H, Tamaki Y, et al
    Associations of right ventricular pulsatile load and cardiac power output to clinical outcomes in heart failure: Difference from systemic circulation.
    J Cardiol. 2022 Dec 8:S0914-5087(22)00311-2. doi: 10.1016/j.jjcc.2022.
    >> Share

  45. OHTE N, Tanaka A, Kitada S, Yamada T, et al
    Influence of left ventricular ejection fraction on the reduction in N-terminal pro-brain natriuretic peptide by canagliflozin in patients with heart failure and type 2 diabetes: a sub analysis of the CANDLE trial.
    J Cardiol. 2022 Dec 5:S0914-5087(22)00295-7. doi: 10.1016/j.jjcc.2022.
    >> Share

  46. NAMBA T, Masaki N, Hitomi Y, Ishinoda Y, et al
    Association of serum nitric oxide metabolite level with mortality in patients undergoing coronary angiography.
    J Cardiol. 2022;80:578-584.
    >> Share

  47. TSUDA E, Ito Y, Kato Y, Sakaguchi H, et al
    Thirty-year outcome in children with hypertrophic cardiomyopathy based on the type.
    J Cardiol. 2022;80:557-562.
    >> Share

    November 2022
  48. KIDA K, Miyajima I, Suzuki N, Greenberg BH, et al
    Nutritional Management of Heart Failure.
    J Cardiol. 2022 Nov 9. pii: S0914-5087(22)00272.
    >> Share

  49. ZHANG T, Gao Z, Chen K
    Exosomal microRNAs: potential targets for the prevention and treatment of diabetic cardiomyopathy.
    J Cardiol. 2022;80:423-431.
    >> Share

    October 2022
  50. LEIVA O, Jenkins A, Rosovsky RP, Leaf RK, et al
    Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation.
    J Cardiol. 2022 Oct 29. pii: S0914-5087(22)00269.
    >> Share

  51. IMAMURA T
    Clinical implication of difficulty initiating sleep in patients with heart failure.
    J Cardiol. 2022 Oct 15. pii: S0914-5087(22)00257.
    >> Share

  52. HASHIMOTO S, Kitakata H, Kohsaka S, Fujisawa D, et al
    Confidence in self-care after heart failure hospitalization.
    J Cardiol. 2022 Oct 11. pii: S0914-5087(22)00254.
    >> Share

    September 2022
  53. NODA T, Kamiya K, Hamazaki N, Nozaki K, et al
    Prognostic impact of the coexistence of hepato-renal dysfunction and frailty in patients with heart failure.
    J Cardiol. 2022 Sep 24. pii: S0914-5087(22)00223.
    >> Share

  54. ISHIZAKA S, Iwano H, Tsujinaga S, Murayama M, et al
    Determinants of exercise capacity in patients with heart failure without left ventricular hypertrophy.
    J Cardiol. 2022 Sep 16. pii: S0914-5087(22)00227.
    >> Share

  55. MAEKAWA Y, Takamisawa I, Takano H, Takayama M, et al
    Percutaneous transluminal septal myocardial ablation: past, present, and future.
    J Cardiol. 2022;80:211-217.
    >> Share

    August 2022
  56. KOIZUMI T, Kamada R, Watanabe M, Yokoshiki H, et al
    Predictors of cardiovascular mortality after an electrical storm in patients with structural heart disease.
    J Cardiol. 2022;80:167-171.
    >> Share

  57. HATANO M, Jimba T, Fujiwara T, Tsuji M, et al
    Late-onset right ventricular failure after continuous-flow left ventricular assist device implantation: case presentation and review of the literature.
    J Cardiol. 2022;80:110-115.
    >> Share

  58. ISHIDO M
    Current status and challenges of Pediatric heart transplantation in Japan.
    J Cardiol. 2022;80:145-148.
    >> Share

    June 2022
  59. KARIM A, Muhammad T, Shah I, Khan J, et al
    A multistrain probiotic reduces sarcopenia by modulating Wnt signaling biomarkers in patients with chronic heart failure.
    J Cardiol. 2022 Jun 21. pii: S0914-5087(22)00152.
    >> Share

  60. AMISAKI R, Kato M, Fujiyama M, Matsuda E, et al
    Difficulty initiating sleep in patients with heart failure: Impact of left atrial pressure.
    J Cardiol. 2022 Jun 17. pii: S0914-5087(22)00136.
    >> Share

  61. YOKOYAMA Y, Kataoka N, Nakai M, Matsuo A, et al
    A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio.
    J Cardiol. 2022;79:727-733.
    >> Share

  62. NODA T, Lu X, Ishiguro Y, Ikuemonisan J, et al
    Cost-effective analysis of automated programming optimization in cardiac resynchronization therapy: Holistic Markov modelling.
    J Cardiol. 2022;79:734-739.
    >> Share

  63. KIUCHI S, Ikeda T
    Management of hypertension associated with cardiovascular failure.
    J Cardiol. 2022;79:698-702.
    >> Share

    April 2022
  64. AMIOKA N, Takaishi A, Nakamura K, Endo T, et al
    Innovative clinical pathway shortened the length of hospital stay and prevented readmission in patients with acute decompensated heart failure.
    J Cardiol. 2022 Apr 12. pii: S0914-5087(22)00074.
    >> Share

    March 2022
  65. IWANO H, Utsunomiya H, Shibayama K, Tanaka H, et al
    Results of PRospect trial to Elucidate the utility of EchocarDiography-based Cardiac ouTput in acute heart failure (PREDICT).
    J Cardiol. 2022 Mar 17. pii: S0914-5087(22)00055.
    >> Share

  66. NAKAI T, Ikeya Y, Kogawa R, Okumura Y, et al
    Cardiac resynchronization therapy: Current status and near-future prospects.
    J Cardiol. 2022;79:352-357.
    >> Share

  67. OKI T, Ishii S, Takigami Y, Eda Y, et al
    Re-worsening left ventricular ejection fraction after response to cardiac resynchronization therapy.
    J Cardiol. 2022;79:358-364.
    >> Share

    February 2022
  68. YOSHIKAWA T
    New paradigm shift in the pharmacotherapy for heart failure-where are we now and where are we heading?
    J Cardiol. 2022 Feb 25. pii: S0914-5087(22)00031.
    >> Share

  69. SATO Y, Yoshihisa A, Takeishi R, Ohara H, et al
    B-type natriuretic peptide is associated with the occurrence of bleeding events in heart failure patients with a history of coronary artery disease.
    J Cardiol. 2022 Feb 22. pii: S0914-5087(22)00026.
    >> Share

  70. KIDA K, Nabeta T, Ishida M, Shiono T, et al
    D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban.
    J Cardiol. 2022 Feb 8. pii: S0914-5087(22)00015.
    >> Share

    January 2022
  71. MIYANAGA S, Komukai K, Kubota T, Shirasaki K, et al
    Cancer and malnutrition were independently associated with a poor prognosis in patients with heart failure.
    J Cardiol. 2022;79:15-20.
    >> Share

  72. WANG S, Jiang C, Zhao L, Sun S, et al
    Metabolic maturation during postnatal right ventricular development switches to heart-contraction regulation due to volume overload.
    J Cardiol. 2022;79:110-120.
    >> Share

  73. BRONS M, Rutten FH, Zuithoff NPA, Oerlemans MIFJ, et al
    Disease management with home telemonitoring aimed at substitution of usual care in the Netherlands: Post-hoc analyses of the e-Vita HF study.
    J Cardiol. 2022;79:1-5.
    >> Share

    December 2021
  74. YAKU H, Kaneda K, Kitamura J, Kato T, et al
    Kampo medicine for the holistic approach to older adults with heart failure.
    J Cardiol. 2021 Dec 30. pii: S0914-5087(21)00366.
    >> Share

  75. KAKUTANI N, Yokota T, Fukushima A, Obata Y, et al
    Impact of citrus fruit intake on the mental health of patients with chronic heart failure.
    J Cardiol. 2021 Dec 23. pii: S0914-5087(21)00359.
    >> Share

  76. SHINOMIYA H, Koyama S, Tanada Y, Takahashi N, et al
    Corrigendum to "Left ventricular end-diastolic pressure and ejection fraction correlate independently with high-sensitivity cardiac troponin-T concentrations in stable heart failure" 65 (2015) 526-530 6.
    J Cardiol. 2021 Dec 22. pii: S0914-5087(21)00317.
    >> Share

  77. FUKATA M, Yamasaki H, Sai E, Ogawa K, et al
    Impact of adaptive cardiac resynchronization therapy in patients with systolic heart failure: Beyond QRS duration and morphology.
    J Cardiol. 2021 Dec 19. pii: S0914-5087(21)00315.
    >> Share

  78. SAITO C, Jujo K, Kametani M, Arai K, et al
    Prognostic impact of right ventricular function affected by pulmonary hypertension in hospitalized heart failure patients.
    J Cardiol. 2021 Dec 18. pii: S0914-5087(21)00279.
    >> Share

  79. SAKU K, Yokota S, Nishikawa T, Kinugawa K, et al
    Interventional heart failure therapy: A new concept fighting against heart failure.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00339.
    >> Share

  80. ODAJIMA S, Tanaka H, Fujimoto W, Kuroda K, et al
    Efficacy of Renin-angiotensin-aldosterone-system inhibitors for heart failure with preserved ejection fraction and left ventricular hypertrophy -from the KUNIUMI Registry Acute Cohort.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00357.
    >> Share

  81. MINATOGUCHI S
    Heart failure and its treatment from the perspective of sympathetic nerve activity.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00337.
    >> Share

  82. YAMAMOTO M, Ishizu T, Seo Y, Nakagawa D, et al
    Pathophysiological role of right ventricular function and interventricular functional mismatch in the development of pulmonary edema in acute heart failure.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00342.
    >> Share

  83. NISHIDA H, Ota T, Onsager D, Grinstein J, et al
    Ten-year, single center experience of ambulatory axillary intra-aortic balloon pump support for heart failure.
    J Cardiol. 2021 Dec 8. pii: S0914-5087(21)00320.
    >> Share

  84. OISHI H, Okumura T, Ohashi K, Kimura Y, et al
    Prognostic impact of transcardiac gradient of follistatin-like 1 reflecting hemodynamics in patients with dilated cardiomyopathy.
    J Cardiol. 2021;78:524-532.
    >> Share

    November 2021
  85. HARADA T, Kagami K, Kato T, Obokata M, et al
    Echocardiography in the diagnostic evaluation and phenotyping of heart failure with preserved ejection fraction.
    J Cardiol. 2021 Nov 29. pii: S0914-5087(21)00313.
    >> Share

  86. YAMASHITA M, Kamiya K, Hamazaki N, Nozaki K, et al
    Work status before admission relates to prognosis in older patients with heart failure partly through social frailty.
    J Cardiol. 2021 Nov 21. pii: S0914-5087(21)00307.
    >> Share

  87. NAKAO Y, Kawakami H, Saito M, Inoue K, et al
    Cost-Effectiveness of long-term tolvaptan administration for chronic heart failure treatment in Japan.
    J Cardiol. 2021 Nov 16. pii: S0914-5087(21)00287.
    >> Share

  88. TSAI YL, Chou RH, Lu YW, Chang CC, et al
    Associations between galectin-1, left ventricular diastolic dysfunction, and heart failure with preserved ejection fraction.
    J Cardiol. 2021 Nov 10. pii: S0914-5087(21)00258.
    >> Share

    October 2021
  89. OKADA M, Inoue K
    Catheter ablation of atrial fibrillation with left ventricular systolic dysfunction: Potential approach to the cause of heart failure-authors' reply.
    J Cardiol. 2021;78:347-348.
    >> Share

    September 2021
  90. IWAHASHI N, Kirigaya J, Abe T, Horii M, et al
    Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment.
    J Cardiol. 2021 Sep 23. pii: S0914-5087(21)00242.
    >> Share

    August 2021
  91. KONISHI M, Akiyama E, Shibata A, Kida K, et al
    Moderate potassium lowering effect of exogenous atrial natriuretic peptide in patients with acute heart failure.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00197.
    >> Share

  92. KANAI M, Yagishita D, Shoda M, Ejima K, et al
    Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00195.
    >> Share

    June 2021
  93. YAMADA T, Haruki S, Minami Y, Numata M, et al
    The C-reactive protein to prealbumin ratio on admission and its relationship with outcome in patients hospitalized for acute heart failure.
    J Cardiol. 2021 Jun 10. pii: S0914-5087(21)00131.
    >> Share

  94. YANAGIHARA K, Kinugasa Y, Kunimi T, Kaneko S, et al
    Child ego state and self-care behavior change in heart failure patients.
    J Cardiol. 2021 Jun 2. pii: S0914-5087(21)00128.
    >> Share

  95. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    >> Share

  96. TOMII D, Horiuchi Y, Gonda Y, Yoshiura D, et al
    The role of the renal resistance index in patients with heart failure with reduced or preserved ejection fraction.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00130.
    >> Share

    May 2021
  97. TSAI YN, Cheng WH, Chang YT, Hsiao YW, et al
    Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmia.
    J Cardiol. 2021 May 28. pii: S0914-5087(21)00108.
    >> Share

  98. HITOMI Y, Nagatomo Y, Yukino M, Yumita Y, et al
    Characterization of tolvaptan response and its impact on the outcome for patients with heart failure.
    J Cardiol. 2021 May 23. pii: S0914-5087(21)00111.
    >> Share

    April 2021
  99. MARUYAMA M, Yasuoka R, Nagano T, Nakazawa G, et al
    Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study.
    J Cardiol. 2021 Apr 30. pii: S0914-5087(21)00091.
    >> Share

  100. NAKAMURA T, Tsujita K
    Current trends and future perspectives for heart failure treatment leveraging cGMP modifiers and the practical effector PKG.
    J Cardiol. 2021 Apr 1. pii: S0914-5087(21)00059.
    >> Share

  101. NAKAJIMA DOI S, Seguchi O, Yamamoto M, Fujita T, et al
    Impact of bridge-to-bridge strategies from paracorporeal to implantable left ventricular assist devices on the pre-heart transplant outcome: A single-center analysis of 134 cases.
    J Cardiol. 2021;77:408-416.
    >> Share

    March 2021
  102. YOKOYAMA H, Shishido K, Tobita K, Moriyama N, et al
    Impact of age on mid-term clinical outcomes and left ventricular reverse remodeling after cardiac resynchronization therapy.
    J Cardiol. 2021;77:254-262.
    >> Share

  103. DAYANAND S, Martinez JM, Figueredo VM, Gupta S, et al
    Mechanical Circulatory Support in Women.
    J Cardiol. 2021;77:209-216.
    >> Share

    February 2021
  104. MAEMURA K, Ikeda Y, Oki T, Yazaki M, et al
    Clinical significance of ischemia-like electrocardiographic finding during heart failure treatment on left ventricular recovery in patients with non-ischemic dilated cardiomyopathy.
    J Cardiol. 2021 Feb 19. pii: S0914-5087(21)00037.
    >> Share

  105. KIKUCHI A, Taniguchi T, Nakamoto K, Sera F, et al
    Feasibility of home-based cardiac rehabilitation using an integrated telerehabilitation platform in elderly patients with heart failure: A pilot study.
    J Cardiol. 2021 Feb 10. pii: S0914-5087(21)00023.
    >> Share

  106. SOEDA T, Okura H, Saito Y, Nakao K, et al
    Clinical characteristics and in-hospital outcomes in patients aged 80 years or over with cardiac troponin-positive acute myocardial infarction -J-MINUET study.
    J Cardiol. 2021;77:139-146.
    >> Share

  107. NAITO Y, Masuyama T, Ishihara M
    Iron and cardiovascular diseases.
    J Cardiol. 2021;77:160-165.
    >> Share

    January 2021
  108. FUJIMOTO W, Konishi A, Iwasaki M, Toh R, et al
    Precipitating factors and clinical impact of early rehospitalization for heart failure in patients with heart failure in Awaji Island, Japan.
    J Cardiol. 2021 Jan 5. pii: S0914-5087(20)30418.
    >> Share

  109. SHIINA Y, Nagao M, Shimomiya Y, Inai K, et al
    Secondary sarcopenia assessed by computed tomography can predict hospitalization for heart failure in adults with Fontan circulation.
    J Cardiol. 2021;77:10-16.
    >> Share

  110. KANAMORI H, Naruse G, Yoshida A, Minatoguchi S, et al
    Morphological characteristics in diabetic cardiomyopathy associated with autophagy.
    J Cardiol. 2021;77:30-40.
    >> Share

    December 2020
  111. TANAKA H, Yamauchi Y, Imanishi J, Hatani Y, et al
    Effect of ivabradine on left ventricular diastolic function of patients with heart failure with preserved ejection fraction -IVA-PEF study.
    J Cardiol. 2020 Dec 31. pii: S0914-5087(20)30417.
    >> Share

  112. NATANZON SS, Mazin I
    Author's reply: The outcome of acute decompensated heart failure stratified by the Norton scale on admission.
    J Cardiol. 2020 Dec 4. pii: S0914-5087(20)30385.
    >> Share

  113. IZUMIDA T, Imamura T
    The outcome of acute decompensated heart failure stratified by the Norton scale on admission.
    J Cardiol. 2020 Dec 3. pii: S0914-5087(20)30386.
    >> Share

  114. IZUMIDA T, Imamura T
    Sarcopenia in patients with cardiovascular disease.
    J Cardiol. 2020;76:636.
    >> Share

    November 2020
  115. KURODA S, Mizukami A, Hiroki J, Shimizu Y, et al
    Clinical impact of serial change in brain natriuretic peptide before and after catheter ablation in patients with atrial fibrillation and heart failure.
    J Cardiol. 2020 Nov 25. pii: S0914-5087(20)30374.
    >> Share

  116. CHANG WT, Lin CH, Hong CS, Liao CT, et al
    The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction.
    J Cardiol. 2020 Nov 21. pii: S0914-5087(20)30359.
    >> Share

  117. HATA R, Kato T, Yaku H, Morimoto T, et al
    Implantable Cardioverter Defibrillator Therapy in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction: An Observation from the KCHF Registry.
    J Cardiol. 2020 Nov 12. pii: S0914-5087(20)30339.
    >> Share

    October 2020
  118. MIRO O, Lopez-Diez MP, Rossello X, Gil V, et al
    Analysis of standards of quality for outcomes in acute heart failure patients directly discharged home from emergency departments and their relationship with the emergency department direct discharge rate.
    J Cardiol. 2020 Oct 11. pii: S0914-5087(20)30307.
    >> Share

    September 2020
  119. KOBAYASHI S, Yoshiga Y, Yano M
    Author's reply: The RyR2 - Targeting therapy against lethal arrhythmia.
    J Cardiol. 2020;76:323-324.
    >> Share

    May 2020
  120. SATO K, Takahashi J, Hao K, Miyata S, et al
    Temporal trends in the prevalence and outcomes of geriatric patients with acute myocardial infarction in Japan-A report from the Miyagi AMI Registry Study.
    J Cardiol. 2020;75:465-472.
    >> Share

    April 2020
  121. KODZISZEWSKA K, Sochanowicz B, Smigielski W, Kruszewski M, et al
    Grey areas and open questions in neprilysin inhibition.
    J Cardiol. 2020;75:462-463.
    >> Share

  122. CHANG HY, Yin WH
    Response to "Grey Areas and Open Questions in Neprilysin Inhibition".
    J Cardiol. 2020;75:463-464.
    >> Share

  123. LIANG Y, Wang J, Yu Z, Zhang M, et al
    Comparison between cardiac resynchronization therapy with and without defibrillator on long-term mortality: A propensity score matched analysis.
    J Cardiol. 2020;75:432-438.
    >> Share

    March 2020
  124. CHANG HY, Chen KC, Fong MC, Feng AN, et al
    Recovery of left ventricular dysfunction after sacubitril/valsartan: predictors and management.
    J Cardiol. 2020;75:233-241.
    >> Share

    September 2019
  125. HAYASHI H, Abe Y, Morita Y, Yamaji Y, et al
    Prognostic significance of moderate primary mitral regurgitation and concomitant paroxysmal atrial fibrillation.
    J Cardiol. 2019 Sep 12. pii: S0914-5087(19)30276.
    >> Share

  126. YAMASAKI H, Sekiguchi Y, Gosho M, Nogami A, et al
    Design and results of aCRT MID-Q study: Adoption of adaptive CRT in patients with normal AV conduction and moderately wide left bundle branch block.
    J Cardiol. 2019 Sep 3. pii: S0914-5087(19)30262.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016